wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38263698-CCB11AEC-257F-44D5-8FFE-0112E963D4E1
Q38263698-CCB11AEC-257F-44D5-8FFE-0112E963D4E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38263698-CCB11AEC-257F-44D5-8FFE-0112E963D4E1
Invited review: Drug development for tauopathies.
P2860
Q38263698-CCB11AEC-257F-44D5-8FFE-0112E963D4E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38263698-CCB11AEC-257F-44D5-8FFE-0112E963D4E1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e41302cc120a28da5e2e9e2200f44c000a77a2b
P2860
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy.